US HB6895 | 2023-2024 | 118th Congress

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on December 22 2023 - 25% progression
Action: 2023-12-22 - Referred to the House Committee on Armed Services.
Pending: House Armed Services Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Defense Production and Active Pharmaceutical Ingredients Act

Sponsors


History

DateChamberAction
2023-12-22HouseReferred to the House Committee on Armed Services.
2023-12-22HouseIntroduced in House

Same As/Similar To

HB2670 (Related) 2023-12-22 - Became Public Law No: 118-31.

Subjects


US Congress State Sources


Bill Comments

feedback